SA was overcharged for its AstraZeneca doses â paying 25% more than high income countries
May 26, 2021, 02:16 PM
facebook
South Africa paid roughly R150 per dose of the now-abandoned AstraZeneca vaccine.
This is more than double what the European Union paid and 25% higher than the average cost to high-income countries.
Higher vaccine costs imposed on poorer nations, coupled with a lack of transparency regarding purchase agreements, is a cause for concern according to anti-corruption group Transparency International.
The price of the Pfizer and Johnson & Johnson vaccines are, however, better aligned with South Africa’s curve.
For more stories go to www.BusinessInsider.co.za.